BeOne Medicines Ltd. (ONC) stock
ONCNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as BEIGF
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 14/301935% above fair value
$416.54+0.58 (+0.14%)
Close on Nov 13, 2026Market cap $47.36BP/E 53.4Yield –
BeOne Medicines enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
BeOne Medicines's enterprise value was $43.51B on Nov 11, 2026, against $34.46B a year earlier. Over the last 5 years it ranged from $8.45B to $43.51B, with a median of $19.94B.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $43.51B | +43.2% |
| 2025 | Dec 31, 2025 | $30.38B | +68.4% |
| 2024 | Dec 31, 2024 | $18.04B | +11.1% |
| 2023 | Dec 29, 2023 | $16.23B | -15.8% |
| 2022 | Dec 30, 2022 | $19.29B | -12.4% |
| 2021 | Dec 31, 2021 | $22.01B | +15.8% |
| 2020 | Dec 31, 2020 | $19.00B | – |
| 2019 | Dec 31, 2019 | -$111.75M | -101.8% |
| 2018 | Dec 31, 2018 | $6.35B | +71.6% |
| 2017 | Dec 29, 2017 | $3.70B | +364.1% |
| 2016 | Dec 30, 2016 | $797.14M | – |
See a number that looks wrong?